|
Volumn 52, Issue 5, 2011, Pages 497-498
|
Comment on Treatment of Psychiatric Illness in Patients with Mitochondrial Disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
ASCORBIC ACID;
CITALOPRAM;
DULOXETINE;
FLUOXETINE;
MAGNESIUM;
MITOCHONDRIAL DNA;
MOCLOBEMIDE;
PSYCHOTROPIC AGENT;
RISPERIDONE;
UBIDECARENONE;
VENLAFAXINE;
ZUCLOPENTHIXOL;
ANXIETY DISORDER;
ATTENTION DEFICIT DISORDER;
DEPRESSION;
DISORDERS OF MITOCHONDRIAL FUNCTIONS;
DRUG MEGADOSE;
DRUG RESPONSE;
DRUG TOLERABILITY;
GENE DELETION;
GENE MUTATION;
HUMAN;
LETTER;
MELAS SYNDROME;
MENTAL DISEASE;
MIGRAINE;
OBSESSIVE COMPULSIVE DISORDER;
TREATMENT RESPONSE;
MALE;
NOTE;
PSYCHOLOGICAL ASPECT;
HUMANS;
MALE;
MELAS SYNDROME;
OBSESSIVE-COMPULSIVE DISORDER;
|
EID: 84856178845
PISSN: 00333182
EISSN: 15457206
Source Type: Journal
DOI: 10.1016/j.psym.2011.01.025 Document Type: Letter |
Times cited : (5)
|
References (5)
|